CTCM-111

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCTCM-111
Drug Alias Namepsoriasis therapy (Chemokine Therapeutics)SempervirineCTCM-111
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionChemokine modulators
TargetsUpdating
Therapy Area/IndicationsPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesChemokine Therapeutics Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChemokine Therapeutics Corp
Active IndicationsN/A
Inactive IndicationsPsoriasis

Other Information

ATC CodeN/A
Related LinksN/A